PB9828
antibody from Boster Biological Technology
Targeting: TGFBR1
ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PB9828 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-TGF beta Receptor I/TGFBR1 Antibody Picoband™
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for TGF BETA RECEPTOR I/TGFBR1 detection. Host: Rabbit.Size: 100μg/vial. Tested applications: WB. Reactive species: Human. TGF BETA RECEPTOR I/TGFBR1 information: Molecular Weight: 55960 MW; Subcellular Localization: Cell membrane; Single-pass type I membrane protein. Cell junction, tight junction; Tissue Specificity: Found in all tissues examined, most abundant in placenta and least abundant in brain and heart.
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15.
The orphan GPR50 receptor interacting with TβRI induces G1/S-phase cell cycle arrest via Smad3-p27/p21 in BRL-3A cells.
Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
Liu Y, Chen X, Xu Y, Yang T, Wang H, Wang Z, Hu Z, Chen L, Zhang Z, Wu Y
Journal of molecular medicine (Berlin, Germany) 2024 Jan;102(1):81-94
Journal of molecular medicine (Berlin, Germany) 2024 Jan;102(1):81-94
The orphan GPR50 receptor interacting with TβRI induces G1/S-phase cell cycle arrest via Smad3-p27/p21 in BRL-3A cells.
Chang C, Wang D, Xi L, Guo X, Wang G, Yu G
Biochemical pharmacology 2022 Aug;202:115117
Biochemical pharmacology 2022 Aug;202:115117
Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
Zhang LL, Jiang XM, Huang MY, Feng ZL, Chen X, Wang Y, Li H, Li A, Lin LG, Lu JJ
Phytomedicine : international journal of phytotherapy and phytopharmacology 2019 Jan;52:32-39
Phytomedicine : international journal of phytotherapy and phytopharmacology 2019 Jan;52:32-39
No comments: Submit comment
No validations: Submit validation data